{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:47:35Z","timestamp":1794541655124,"version":"4.9.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nutr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Psoriasis is a continuing, periodic, immune\u2011mediated, fiery skin disease branded by hyper proliferation of epidermal keratinocytes and accompanying with inflammatory cellular infiltrate in both dermis and epidermis. Immunomodulation could be an important effect of vitamin D in Psoriasis. This case-control study was designed to measure serum 25-hydroxy vitamin D levels in patients with psoriasis and healthy controls and to find out clinical correlation, if any. Six hundred two (n\u2009=\u2009602) subjects (285 cases and 317 controls) were taken for the study. Cases and controls were frequency matched with respect to age and gender. Various demographic and clinical details were taken using a questionnaire. Chemiluminescence Micro Particle Immunoassay was used to estimate serum 25-hydroxy vitamin D levels. The vitamin D deficiency in psoriasis patients was 60.0% vs. 17.5% in controls (P\u2009&lt;\u20090.001) with mean vitamin D levels of 28.3\u2009\u00b1\u200913.9 ng\/ml in psoriasis patient\u2019s vs. 37.9\u2009\u00b1\u20099.7 ng\/ml in controls. Vitamin D deficiency was found to be associated with psoriasis independently of gender, age, smoking status, family history, hypertension, chronic medication, nail changes, duration of symptoms and severity of disease. Vitamin D levels were seven times lower in patients with Psoriasis as compared to controls. Reduced vitamin D levels are related to duration and clinical severity of the disease. Early detection of vitamin D deficiency and timely intervention could lead to better clinical outcome and improved quality of life in psoriasis patients.<\/jats:p>","DOI":"10.1186\/s40795-022-00610-y","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T13:04:46Z","timestamp":1666184686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Vitamin D status in Psoriasis: impact and clinical correlations"],"prefix":"10.1186","volume":"8","author":[{"given":"Ghulam Hassan","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Guldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4430-2647","authenticated-orcid":false,"given":"Mosin Saleem","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir","family":"Yasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"key":"610_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1046\/j.1468-3083.2003.00622.x","volume":"17","author":"K Holubar","year":"2003","unstructured":"Holubar K. Psoriasis and parapsoriasis: since 200 and 100 years, respectively. J Eur Acad Dermatol. 2003;17:126\u20137.","journal-title":"J Eur Acad Dermatol"},{"key":"610_CR2","first-page":"479","volume":"141","author":"A Shai","year":"2002","unstructured":"Shai A, Vardy D, Zvulunov A. Psoriasis, biblical afflictions and patient\u2019s dignity. Harefuah. 2002;141:479\u201382.","journal-title":"Harefuah"},{"key":"610_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.0022-202x.2001.01656.x","volume":"118","author":"JE Guojonsson","year":"2002","unstructured":"Guojonsson JE, Valdimarsson H, Karason A, et al. HLA-CW6-positive and HLA-CW6-negative patients with psoriasis vulgaris have distinct clinical features. J Investig Dermatol. 2002;118:362\u20135.","journal-title":"J Investig Dermatol"},{"key":"610_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis Lancet. 2021;397:1301\u201315.","journal-title":"Psoriasis Lancet"},{"issue":"8","key":"610_CR5","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/mnfr.200900468","volume":"54","author":"JK Lai","year":"2010","unstructured":"Lai JK, Lucas RM, Clements MS, Harrison SL, Banks E. Assessing 25-Hydroxy vitamin D status: pitfalls for the unwary. Mol Nutr Food Res. 2010;54(8):1062\u201371.","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"610_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1210\/jc.2009-1773","volume":"95","author":"JS Adams","year":"2010","unstructured":"Adams JS, Hewison M. Update in 25-Hydroxy vitamin D. J Clin Endocrinol Metab. 2010;95(2):471\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"610_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/1346-8138.13305","volume":"43","author":"C Mattozzi","year":"2016","unstructured":"Mattozzi C, Paolino G, Richetta AG, Calvieri S. Psoriasis. 25-Hydroxy vitamin D and the importance of the cutaneous barrier\u2019s integrity: an update. J Dermatol. 2016;43(5):507\u201314.","journal-title":"J Dermatol"},{"issue":"4","key":"610_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4103\/0378-6323.159928","volume":"81","author":"B Wadhwa","year":"2015","unstructured":"Wadhwa B, Relhan V, Goel K, Kochhar AM, Garg VK. Vitamin D and skin diseases: a review. Indian J Dermatol Venereol Leprol. 2015;81(4):344\u201355.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"610_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000250839","volume":"157","author":"T Fredriksson","year":"1978","unstructured":"Fredriksson T, Pettersson U. Severe psoriasis\u2013oral therapy with a new retinoid. Dermatology. 1978;157(4):238\u201344.","journal-title":"Dermatology"},{"issue":"1","key":"610_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/09546630310019382","volume":"15","author":"SR Feldman","year":"2004","unstructured":"Feldman SR. A quantitative definition of severe psoriasis for use in clinical trials. J Dermatol Treat. 2004;15(1):27\u20139.","journal-title":"J Dermatol Treat"},{"issue":"4","key":"610_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2133.2006.07389.x","volume":"155","author":"J Berth-Jones","year":"2006","unstructured":"Berth-Jones J, Grotzinger K, Rainville C, et al. A study examining inter\u2010and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician\u2019s Global Assessment and Lattice System Physician\u2019s Global Assessment. Br J Dermatol. 2006;155(4):707\u201313.","journal-title":"Br J Dermatol"},{"issue":"5","key":"610_CR12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2133.2005.06502.x","volume":"152","author":"AY Finlay","year":"2005","unstructured":"Finlay AY. Current severe psoriasis and the rule of tens. Br J Dermatol. 2005;152(5):861\u20137.","journal-title":"Br J Dermatol"},{"key":"610_CR13","unstructured":"Pavithran K, Karunakaran M, Aparna P, Raghunath S. Disorders of keratinization. S. Sacchidanand editor. IADVL Textbook of Dermatology. 3rd ed. Bhalani Publishing House; 2008. pp.\u00a01009\u201311."},{"issue":"4","key":"610_CR14","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jaad.2005.11.1079","volume":"54","author":"L Mallbris","year":"2006","unstructured":"Mallbris L, Granath F, Hamsten A, St\u00e5hle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol. 2006;54(4):614\u201321.","journal-title":"J Am Acad Dermatol"},{"key":"610_CR15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/clinchem\/41.1.73","volume":"41","author":"M Summers","year":"1995","unstructured":"Summers M, Booth T, Brockas T, et al. Luminogenic Reagent Using 3-Chloro-4-Hydroxy Acetanilide to Enhance Peroxidase Luminol Chemiluminescence. Clin Chem. 1995;41:73\u20133.","journal-title":"Clin Chem"},{"issue":"7","key":"610_CR16","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of 25-Hydroxy vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"610_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jdv.12163","volume":"27","author":"C Horreau","year":"2013","unstructured":"Horreau C, Pouplard C, Brenaut E, et al. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol. 2013;27:12\u201329.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"610_CR18","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/archderm.141.12.1537","volume":"141","author":"JM Gelfand","year":"2005","unstructured":"Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141(12):1537\u201341.","journal-title":"Arch Dermatol"},{"issue":"2","key":"610_CR19","first-page":"67","volume":"42","author":"TK Mehta","year":"1976","unstructured":"Mehta TK, Shah RN, Marquis L. A Study of 300 Cases of Psoriasis. Indian J Dermatol Venereol Leprol. 1976;42(2):67\u201372.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"610_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263\u201371.","journal-title":"Lancet"},{"issue":"2","key":"610_CR21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/bjd.12670","volume":"170","author":"AW Armstrong","year":"2014","unstructured":"Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol. 2014;170(2):304\u201314.","journal-title":"Br J Dermatol"},{"issue":"5","key":"610_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1365-4632.2005.01925.x","volume":"44","author":"S Davidson","year":"2005","unstructured":"Davidson S, Blomqvist K, Molin L, et al. Lifestyle of Nordic people with psoriasis. Int J Dermatol. 2005;44(5):378\u201383.","journal-title":"Int J Dermatol"},{"issue":"7","key":"610_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","volume":"298","author":"DM Sommer","year":"2007","unstructured":"Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2007;298(7):321.","journal-title":"Arch Dermatol Res"},{"key":"610_CR24","first-page":"7","volume":"18","author":"P Rahman","year":"2000","unstructured":"Rahman P, Schentag CT, Beaton M, Gladman DD. Comparison of clinical and immunogenetic features in familial versus sporadic psoriatic arthritis. Clin Exp Rheumatol. 2000;18:7\u201312.","journal-title":"Clin Exp Rheumatol"},{"key":"610_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/ard.2008.089367","volume":"68","author":"V Chandran","year":"2009","unstructured":"Chandran V, Schentag CT, Brockbank JE, et al. Familial aggregation of psoriatic arthritis. Ann Rheum Dis. 2009;68:664\u20137.","journal-title":"Ann Rheum Dis"},{"key":"610_CR26","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","volume":"97","author":"PE Stuart","year":"2015","unstructured":"Stuart PE, Nair RP, Tsoi LC, et al. Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture. Am J Hum Genet. 2015;97:816\u201336.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"610_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2133.1994.tb03380.x","volume":"130","author":"K Poikolainen","year":"1994","unstructured":"Poikolainen K, Reunala T, Karvonen J. Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol. 1994;130(4):473\u20137.","journal-title":"Br J Dermatol"},{"issue":"3","key":"610_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000348865","volume":"26","author":"A Farkas","year":"2013","unstructured":"Farkas A, Kem\u00e9ny L. Alcohol, liver, systemic inflammation and skin: a focus on patients with psoriasis. Skin Pharmacol Physiol. 2013;26(3):119\u201326.","journal-title":"Skin Pharmacol Physiol"},{"issue":"1","key":"610_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.0022-202X.2005.23681.x","volume":"125","author":"L Naldi","year":"2005","unstructured":"Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case\u2013control study. J Investig Dermatol. 2005;125(1):61\u20137.","journal-title":"J Investig Dermatol"},{"issue":"3","key":"610_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/HJH.0b013e32835bcce1","volume":"31","author":"AW Armstrong","year":"2013","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2013;31(3):433\u201342.","journal-title":"J Hypertens"},{"issue":"5","key":"610_CR31","first-page":"RA155","volume":"11","author":"UN Das","year":"2005","unstructured":"Das UN. Is angiotensin-II an endogenous pro-inflammatory molecule? Med Sci Monit. 2005;11(5):RA155\u2013162.","journal-title":"Med Sci Monit"},{"issue":"3","key":"610_CR32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.0022-202X.2004.23611.x","volume":"124","author":"L Mallbris","year":"2005","unstructured":"Mallbris L, Larsson P, Bergqvist S, Ving\u00e5rd E, Granath F, St\u00e5hle M. Psoriasis phenotype at disease onset: clinical characterization of 400 adult cases. J Investig Dermatol. 2005;124(3):499\u2013504.","journal-title":"J Investig Dermatol"},{"issue":"6","key":"610_CR33","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.clindermatol.2007.08.015","volume":"25","author":"L Fry","year":"2007","unstructured":"Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol. 2007;25(6):606\u201315.","journal-title":"Clin Dermatol"},{"issue":"5","key":"610_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ad.2011.02.007","volume":"102","author":"S Armesto","year":"2011","unstructured":"Armesto S, Esteve A, Coto-Segura P, et al. Nail psoriasis in individuals with psoriasis vulgaris: a study of 661 patients. Actas Dermo-Sifiliogr\u00e1ficas. 2011;102(5):365\u201372.","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"issue":"3\u20134","key":"610_CR35","first-page":"51","volume":"35","author":"S Morimoto","year":"1985","unstructured":"Morimoto S, Kumahara Y. A patient with psoriasis cured by 1 alpha-hydroxy 25-Hydroxy vitamin D3. Med J Osaka Univ. 1985;35(3\u20134):51.","journal-title":"Med J Osaka Univ"},{"issue":"5","key":"610_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/1346-8138.13305","volume":"43","author":"C Mattozzi","year":"2016","unstructured":"Mattozzi C, Paolino G, Richetta AG, Calvieri S. Psoriasis. 25-Hydroxy vitamin D and the importance of the cutaneous barrier\u2019s integrity: an update. J Dermatol. 2016;43(5):50\u20136.","journal-title":"J Dermatol"},{"issue":"3","key":"610_CR37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jaad.2012.10.051","volume":"68","author":"F Ricceri","year":"2013","unstructured":"Ricceri F, Pescitelli L, Tripo L, Prignano F. Deficiency of serum concentration of 25-hydroxy25-Hydroxy vitamin D correlates with severity of disease in chronic plaque psoriasis. J Am Acad Dermatol. 2013;68(3):511\u20132.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"610_CR38","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jaad.2012.01.040","volume":"67","author":"J Orgaz-Molina","year":"2012","unstructured":"Orgaz-Molina J, Buend\u00eda-Eisman A, Arrabal-Polo MA, Ruiz JC, Arias-Santiago S. Deficiency of serum concentration of 25-hydroxy25-Hydroxy vitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol. 2012;67(5):931\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"610_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12816\/0025592","volume":"10","author":"RM Gutte","year":"2014","unstructured":"Gutte RM, Pahuja V. A case-control study of 25-hydroxy25-Hydroxy vitamin D deficiency in psoriasis patients. Egypt Dermatol Online J. 2014;10(1):1\u20134.","journal-title":"Egypt Dermatol Online J"},{"issue":"6","key":"610_CR40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.5114\/ada.2016.63883","volume":"33","author":"B Bergler-Czop","year":"2016","unstructured":"Bergler-Czop B, Brzezi\u0144ska-Wcis\u0142o L. Serum 25-Hydroxy vitamin D level\u2013the effect on the clinical course of psoriasis. Adv Dermatol Allergol. 2016;33(6):445.","journal-title":"Adv Dermatol Allergol"},{"issue":"3","key":"610_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1203475415622207","volume":"20","author":"M Maleki","year":"2016","unstructured":"Maleki M, Nahidi Y, Azizahari S, Meibodi NT, Hadianfar A. Serum 25-OH 25-Hydroxy vitamin D Level in Psoriatic Patients and Comparison with Control Subjects. J Cutan Med Surg. 2016;20(3):207\u201310.","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"610_CR42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2133.2011.10699.x","volume":"166","author":"P Gisondi","year":"2012","unstructured":"Gisondi P, Rossini M, Di Cesare A, et al. 25-Hydroxy vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol. 2012;166(3):505\u201310.","journal-title":"Br J Dermatol"},{"key":"610_CR43","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1530\/EJE-12-0283","volume":"167","author":"LL Schierbeck","year":"2012","unstructured":"Schierbeck LL, Rejnmar L, Landbo TC, et al. 25-Hydroxy vitamin D deficiency in postmenopausal, healthy women predicts increased cardiovascular events: a 16-year follow-up study. Eur J Endocrinol. 2012;167:553\u201360.","journal-title":"Eur J Endocrinol"},{"key":"610_CR44","doi-asserted-by":"crossref","unstructured":"Naesgaard PA, Leon de la Fuente RA, Nilsen ST, et al. 25-Hydroxy vitamin D predicts all-cause and cardiac mortality in females with suspected acute coronary syndrome; a comparison with brain natruretic peptide and high-sensitivity C\u2013reactive protein. Cardiol Res Pract. 2013; 2013: 398034.","DOI":"10.1155\/2013\/398034"},{"key":"610_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ecl.2013.02.004","volume":"42","author":"JC Gallagher","year":"2013","unstructured":"Gallagher JC. 25-Hydroxy vitamin D and Aging. Endocrinol Metab Clin North Am. 2013;42:319\u201332.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"610_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1515\/jomb-2017-0002","volume":"36","author":"MA Serdar","year":"2017","unstructured":"Serdar MA, BatuCan B, Kilercik M, et al. Analysis of changes in parathyroid hormone and 25 (OH) 25-Hydroxy vitamin D level with respect to age, gender and season: a data mining study. J Med Biochem. 2017;36:73\u201383.","journal-title":"J Med Biochem"},{"key":"610_CR47","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/BF03549778","volume":"53","author":"D Mellstro\u00c8m","year":"1993","unstructured":"Mellstro\u00c8m D, Johansson C, Johnell O, et al. Osteoporosis, metabolic aberrations, and increased risk for vertebral fractures after partial gastrectomy. Calcif Tissue Int. 1993;53:370\u20137.","journal-title":"Calcif Tissue Int"},{"key":"610_CR48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/jbmr.5650060404","volume":"6","author":"EA Krall","year":"1991","unstructured":"Krall EA, Dawson-Hughes B. Smoking and bone loss among postmenopausal women. J Bone Miner Res. 1991;6:331\u20138.","journal-title":"J Bone Miner Res"},{"key":"610_CR49","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/ajcn\/35.2.366","volume":"35","author":"JT Wack","year":"1982","unstructured":"Wack JT, Rodin J. Smoking and its effects on body weight and systems of calorie regulation. Am J Clin Nutr. 1982;35:366\u201380.","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"610_CR50","first-page":"1312","volume":"138","author":"MI Querales","year":"2010","unstructured":"Querales MI, Cruces ME, Rojas S, S\u00e1nchez L. Association between 25-Hydroxy vitamin D deficiency and metabolic syndrome. Rev M\u00e9dica Chile. 2010;138(10):1312\u20138.","journal-title":"Rev M\u00e9dica Chile"},{"issue":"2","key":"610_CR51","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2340\/00015555-1642","volume":"94","author":"J Orgaz-Molina","year":"2014","unstructured":"Orgaz-Molina J, Magro-Checa C, Arrabal-Polo MA, et al. Association of 25-hydroxy25-Hydroxy vitamin D with metabolic syndrome in patients with psoriasis: a case-control study. Acta Derm Venereol. 2014;94(2):142\u20135.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"610_CR52","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11154-017-9411-6","volume":"18","author":"L Barrea","year":"2017","unstructured":"Barrea L, Savanelli MC, Somma CD, et al. 25-Hydroxy vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist. Rev Endocr Metab Disord. 2017;18(2):195\u2013205.","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"610_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1089\/dna.2013.2217","volume":"33","author":"AG Richetta","year":"2014","unstructured":"Richetta AG, Silvestri V, Giancristoforo S, et al. A1012G Promoter Polymorphism of 25-Hydroxy vitamin D Receptor Gene Is Associated with Psoriasis Risk and Lower Allele- Specific Expression. DNA Cell Biol. 2014;33(2):102\u20139.","journal-title":"DNA Cell Biol"},{"key":"610_CR54","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/ced.13381","volume":"43","author":"YH Lee","year":"2018","unstructured":"Lee YH, Song GG. Association between circulating 25-hydroxy25-Hydroxy vitamin D levels and psoriasis, and correlation with disease severity: A meta-analysis. Clin Exp Dermatol. 2018;43:529\u201335.","journal-title":"Clin Exp Dermatol"},{"issue":"25","key":"610_CR55","doi-asserted-by":"publisher","first-page":"e11185","DOI":"10.1097\/MD.0000000000011185","volume":"97","author":"A Filoni","year":"2018","unstructured":"Filoni A, Vestita M, Congedo M, Giudice G, Tafuri S, Bonamonte D. Association between psoriasis and 25-Hydroxy vitamin D: Duration of disease correlates with decreased 25-Hydroxy vitamin D serum levels: An observational case-control study. Med (Baltim). 2018;97(25):e11185.","journal-title":"Med (Baltim)"},{"key":"610_CR56","first-page":"17","volume":"1","author":"SA Abdalla","year":"2014","unstructured":"Abdalla SA, Abdrabo AA. Assessment of 25\u2013hydroxy25-Hydroxy vitamin D in serum of psoriatic sudanese patients: a case\u2013control study. Br J Med Health Res. 2014;1:17\u201322.","journal-title":"Br J Med Health Res"},{"issue":"2","key":"610_CR57","first-page":"155","volume":"153","author":"C Mattozzi","year":"2018","unstructured":"Mattozzi C, Paolino G, Salvi M, et al. Correlation between plasmatic levels of 25-Hydroxy vitamin D and PASI score: our experience and mini-review of the literature. G Ital Dermatol Venereol. 2018;153(2):155\u201360.","journal-title":"G Ital Dermatol Venereol"},{"key":"610_CR58","doi-asserted-by":"crossref","unstructured":"Holick MF. High prevalence of 25-Hydroxy vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006; 81: 353\u2013373.","DOI":"10.4065\/81.3.353"},{"key":"610_CR59","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1600-0625.2007.00570.x","volume":"16","author":"J Reichrath","year":"2007","unstructured":"Reichrath J. Vitamin D and the skin: An ancient friend, revisited. Exp Dermatol. 2007;16:618\u201325.","journal-title":"Exp Dermatol"},{"key":"610_CR60","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/1523-1747.ep12343866","volume":"106","author":"R Gniadecki","year":"1996","unstructured":"Gniadecki R. Stimulation versus inhibition of keratinocyte growth by 1,25-dihydroxyvitamin D3: dependence on cell culture conditions. J Invest Dermatol. 1996;106:510\u20136.","journal-title":"J Invest Dermatol"},{"key":"610_CR61","doi-asserted-by":"publisher","first-page":"e0141770","DOI":"10.1371\/journal.pone.0141770","volume":"10","author":"EK Calton","year":"2015","unstructured":"Calton EK, Keane KN, Newsholme P, Soares MJ. The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS ONE. 2015;10:e0141770.","journal-title":"PLoS ONE"},{"key":"610_CR62","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.4049\/jimmunol.1102412","volume":"188","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Leung DY, Richers BN, et al. Vitamin D inhibits monocyte\/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188:2127\u201335.","journal-title":"J Immunol"},{"key":"610_CR63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.diabres.2006.10.007","volume":"77","author":"A Giulietti","year":"2007","unstructured":"Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a proinflammatory profile. 1,25-dihydroxyvitamin D(3) works as antiinflammatory. Diabetes Res Clin Pract. 2007;77:47\u201357.","journal-title":"Diabetes Res Clin Pract"},{"key":"610_CR64","doi-asserted-by":"publisher","first-page":"L43","DOI":"10.1210\/jc.2016-1342","volume":"101","author":"G Muscogiuri","year":"2016","unstructured":"Muscogiuri G, Orio F, Colao A. Letter to the editor: vitamin D: a wonder drug for the cure of type 2 diabetes? J Clin Endocrinol Metab. 2016;101:L43\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"610_CR65","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","volume":"288","author":"HM Lakka","year":"2002","unstructured":"Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709\u201316.","journal-title":"JAMA"},{"key":"610_CR66","first-page":"17","volume":"8","author":"W Abramovits","year":"2009","unstructured":"Abramovits W. Calcitriol 3 microg\/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy. J Drugs Dermatol. 2009;8:17\u201322.","journal-title":"J Drugs Dermatol"},{"key":"610_CR67","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2340\/00015555-0290","volume":"87","author":"GM Ezquerra","year":"2007","unstructured":"Ezquerra GM, Regana MS, Millet PU. Combination of acitretin and oral calcitriol for treatment of plaque-type psoriasis. Acta Derma Venereol. 2007;87:449\u201350.","journal-title":"Acta Derma Venereol"},{"key":"610_CR68","doi-asserted-by":"crossref","unstructured":"Fu LW, Vender R. Systemic role for vitamin d in the treatment of psoriasis and metabolic syndrome. Dermatol Res Pract. 2011; 2011:276079.","DOI":"10.1155\/2011\/276079"}],"container-title":["BMC Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-022-00610-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40795-022-00610-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-022-00610-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T04:03:45Z","timestamp":1701230625000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnutr.biomedcentral.com\/articles\/10.1186\/s40795-022-00610-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["610"],"URL":"https:\/\/doi.org\/10.1186\/s40795-022-00610-y","relation":{},"ISSN":["2055-0928"],"issn-type":[{"value":"2055-0928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,19]]},"assertion":[{"value":"6 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved under the protocol no. 2015\/243 by Yenepoya University Ethics Committee vide order No. YUEC81\/2016 Dated: 12.01.2016 in accordance with the Declaration of Helsinki. The study was performed with informed consent from all individuals included in this study and following all the guidelines for experimental investigations required by the Institutional Review Board or Ethics Committee of which all authors are affiliated.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no financial or non-financial interests that are directly or indirectly related to the work submitted for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}